Cartron G - Search Results

1

[Therapeutic monoclonal antibodies in onco-hematology].

Cartron G, Rossi JF. Cartron G, et al. Med Sci (Paris). 2009 Dec;25(12):1085-9. doi: 10.1051/medsci/200925121085. Med Sci (Paris). 2009. PMID: 20035683 Free article. Review. French.

2

Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study.

Cartron G, Zhao-Yang L, Baudard M, Kanouni T, Rouillé V, Quittet P, Klein B, Rossi JF. Cartron G, et al. J Clin Oncol. 2008 Jun 1;26(16):2725-31. doi: 10.1200/JCO.2007.13.7729. Epub 2008 Apr 21. J Clin Oncol. 2008. PMID: 18427151 Free PMC article. Clinical Trial.

3

[Monoclonal antibody therapy for non-Hodgkin's lymphoma].

Paul F, Rossi JF, Cartron G. Paul F, et al. Among authors: cartron g. Rev Prat. 2010 Jan 20;60(1):59-63. Rev Prat. 2010. PMID: 20222313 French.

4

Interindividual variability of response to rituximab: from biological origins to individualized therapies.

Cartron G, Trappe RU, Solal-Céligny P, Hallek M. Cartron G, et al. Clin Cancer Res. 2011 Jan 1;17(1):19-30. doi: 10.1158/1078-0432.CCR-10-1292. Clin Cancer Res. 2011. PMID: 21208903 Review.

5

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Caraux A, Vincent L, Bouhya S, Quittet P, Moreaux J, Requirand G, Veyrune JL, Olivier G, Cartron G, Rossi JF, Klein B. Caraux A, et al. Among authors: cartron g. Oncotarget. 2012 Nov;3(11):1335-47. doi: 10.18632/oncotarget.650. Oncotarget. 2012. PMID: 23154454 Free PMC article.

6

Obinutuzumab: a new class of anti-CD20 monoclonal antibody.

Gagez AL, Cartron G. Gagez AL, et al. Among authors: cartron g. Curr Opin Oncol. 2014 Sep;26(5):484-91. doi: 10.1097/CCO.0000000000000107. Curr Opin Oncol. 2014. PMID: 25014645 Review.

7

The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism.

Allende-Vega N, Krzywinska E, Orecchioni S, Lopez-Royuela N, Reggiani F, Talarico G, Rossi JF, Rossignol R, Hicheri Y, Cartron G, Bertolini F, Villalba M. Allende-Vega N, et al. Among authors: cartron g. Oncotarget. 2015 Aug 7;6(22):19228-45. doi: 10.18632/oncotarget.4653. Oncotarget. 2015. PMID: 26231043 Free PMC article.

8

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.

Krzywinska E, Allende-Vega N, Cornillon A, Vo DN, Cayrefourcq L, Panabieres C, Vilches C, Déchanet-Merville J, Hicheri Y, Rossi JF, Cartron G, Villalba M. Krzywinska E, et al. Among authors: cartron g. EBioMedicine. 2015 Aug 13;2(10):1364-76. doi: 10.1016/j.ebiom.2015.08.021. eCollection 2015 Oct. EBioMedicine. 2015. PMID: 26629531 Free PMC article.

9

Differential effects of lenalidomide during plasma cell differentiation.

Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, Ceballos P, Cartron G, Rossi JF, Moreaux J, Chopra R, Klein B. Jourdan M, et al. Among authors: cartron g. Oncotarget. 2016 May 10;7(19):28096-111. doi: 10.18632/oncotarget.8581. Oncotarget. 2016. PMID: 27057635 Free PMC article.

10

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity.

Krzywinska E, Cornillon A, Allende-Vega N, Vo DN, Rene C, Lu ZY, Pasero C, Olive D, Fegueux N, Ceballos P, Hicheri Y, Sobecki M, Rossi JF, Cartron G, Villalba M. Krzywinska E, et al. Among authors: cartron g. PLoS One. 2016 Apr 21;11(4):e0150434. doi: 10.1371/journal.pone.0150434. eCollection 2016. PLoS One. 2016. PMID: 27100180 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

253 results

Search Page